| Date Filed | Type | Description |
| 03/02/2023 |
4
| SALEKI-GERHARDT AZITA (EVP, OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 33,359 shares
@ $154.28, valued at
$5.1M
Sold 26,990 shares
@ $155, valued at
$4.2M
Sold 9,220 shares
@ $153.05, valued at
$1.4M
Sold 780 shares
@ $153.39, valued at
$119.6k
Exercised 26,990 options to buy
@ $51.42, valued at
$1.4M
|
|
| 02/21/2023 |
4
| SALEKI-GERHARDT AZITA (EVP, OPERATIONS) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 48,127 shares
@ $0
Granted 11,229 shares
@ $0
Granted 8,560 shares
@ $0
Granted 7,380 shares
@ $0
Sold 14,246 shares
@ $149.13, valued at
$2.1M
Sold 10,754 shares
@ $150.05, valued at
$1.6M
Granted 22,957 options to buy
@ $149.62, valued at
$3.4M
Exercised 25,000 options to buy
@ $51.42, valued at
$1.3M
|
|
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| SALEKI-GERHARDT AZITA (EVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 17,426 shares
@ $98, valued at
$1.7M
|
|
| 11/12/2020 |
4/A
| SALEKI-GERHARDT AZITA (EVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 4,800 shares
@ $93.61, valued at
$449.3k
Exercised 4,800 options to buy
@ $24.2082, valued at
$116.2k
|
|
| 11/06/2020 |
4
| SALEKI-GERHARDT AZITA (EVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 4,800 shares
@ $93.61, valued at
$449.3k
|
|
| 05/01/2020 |
4
| SALEKI-GERHARDT AZITA (Director) has filed a Form 4 on ENTEGRIS INC|
Txns:
| Granted 2,567 shares
@ $0 |
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2019 |
4
| SALEKI-GERHARDT AZITA (Director) has filed a Form 4 on ENTEGRIS INC|
Txns:
| Granted 3,569 shares
@ $0 |
|
| 03/06/2019 |
4
| SALEKI-GERHARDT AZITA (EVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 15,797 shares
@ $79.0327, valued at
$1.2M
|
|
| 03/04/2019 |
4
| SALEKI-GERHARDT AZITA (EVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 12,569 shares
@ $79.41, valued at
$998.1k
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2018 |
4
| SALEKI-GERHARDT AZITA (Director) has filed a Form 4 on ENTEGRIS INC|
Txns:
| Granted 4,090 shares
@ $0 |
|
| 03/02/2018 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 12,683 shares
@ $118.26, valued at
$1.5M
Sold 1,337 shares
@ $117.7695, valued at
$157.5k
|
|
| 02/16/2018 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 7,080 shares
@ $0
Granted 8,283 shares
@ $0
Granted 7,170 shares
@ $0
Granted 23,160 options to buy
@ $114.36, valued at
$2.6M
|
|
| 09/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2016 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 42,370 options to buy
@ $54.86, valued at
$2.3M
|
|
| 02/09/2016 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 2,112 shares
@ $56.76, valued at
$119.9k
Exercised 3,400 options to buy
@ $22.9407, valued at
$78k
|
|
| 03/03/2015 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 5,901 shares
@ $60.52, valued at
$357.1k
Sold 2,112 shares
@ $60.467, valued at
$127.7k
Paid exercise price by delivering 4,592 shares
@ $60.5, valued at
$277.8k
|
|
| 02/23/2015 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 26,740 shares
@ $0
Granted 52,870 options to buy
@ $58.88, valued at
$3.1M
|
|
| 02/11/2015 |
4
| SALEKI-GERHARDT AZITA (SVP, Operations) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 1,425 shares
@ $56.9, valued at
$81.1k
Exercised 2,250 options to buy
@ $24.0731, valued at
$54.2k
|
|
|